Literature DB >> 12722924

Glyceraldehyde 3-phosphate dehydrogenase and endothelin-1 immunoreactivity is associated with cerebral white matter damage in dentatorubral-pallidoluysian atrophy.

Masaki Shiozawa1, Yuken Fukutani, Nobutaka Arai, Nigel J Cairns, Toshio Mizutani, Kiminori Isaki, Peter L Lantos, Yuji Wada.   

Abstract

DRPLA is a rare neurodegenerative disorder caused by CAG triplet elongation on chromosome 12p. In addition to neurodegeneration of both the dentatorubral and pallidoluysian systems, there is cerebral white matter damage, especially in older cases. Intracellular accumulation of DRPLA protein is widespread in the central nervous system, and DRPLA protein has been shown to immobilize glyceraldehyde 3-phosphate dehydrogenase (GAPDH), which regulates glycolysis and controls mRNA of tissue-type plasminogen activator (tPA) in tissue restoration. However, little is known about the pathogenesis regarding the formation of cerebral white matter damage in DRPLA. Therefore, the pathology of this damage was investigated by examining markers of glycolysis and related processes. Nine clinically and pathologically confirmed DRPLA cases were used in the present study. CAG triplet elongation on chromosome 12p was confirmed in all cases where tissue was available for genotyping (seven cases). PAS and immunohistochemistry with antibodies to GFAP, GAPDH and endothelin-1 were used to demonstrate astrocytosis. The polysaccharides storage state with PAS-positive astrocytes was detected in seven cases. GAPDH- and endothelin-1-positive endothelium and astrocytes were observed in two cases with GFAP-positivity. Based on the biochemical process together with the present results, GAPDH and endothelin-1 immunoreactivity is associated with this damage and the mismetabolism of polysaccharides caused by CAG triplet elongation on chromosome 12p may contribute to the formation of the cerebral white matter damage in DRPLA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12722924     DOI: 10.1046/j.1440-1789.2003.00480.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  7 in total

Review 1.  The diverse functions of GAPDH: views from different subcellular compartments.

Authors:  Carlos Tristan; Neelam Shahani; Thomas W Sedlak; Akira Sawa
Journal:  Cell Signal       Date:  2010-08-19       Impact factor: 4.315

Review 2.  Protein S-nitrosylation: role for nitric oxide signaling in neuronal death.

Authors:  Neelam Shahani; Akira Sawa
Journal:  Biochim Biophys Acta       Date:  2011-07-23

Review 3.  Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders.

Authors:  Mark D Berry
Journal:  J Psychiatry Neurosci       Date:  2004-09       Impact factor: 6.186

4.  Hypoalbuminemia in early onset dentatorubral-pallidoluysian atrophy due to leakage of albumin in multiple organs.

Authors:  Shigehiro Nagai; Yoshiaki Saito; Yukari Endo; Takashi Saito; Kenji Sugai; Akihiko Ishiyama; Hirofumi Komaki; Eiji Nakagawa; Masayuki Sasaki; Kimiteru Ito; Yuko Saito; Sayuri Sukigara; Masayuki Ito; Yu-Ichi Goto; Shuichi Ito; Kentaro Matsuoka
Journal:  J Neurol       Date:  2012-12-23       Impact factor: 4.849

Review 5.  Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins.

Authors:  D Allan Butterfield; Erika M Palmieri; Alessandra Castegna
Journal:  Expert Rev Proteomics       Date:  2016       Impact factor: 3.940

6.  Case report of optic atrophy in Dentatorubropallidoluysian Atrophy (DRPLA).

Authors:  Michael R Silver; Kapil D Sethi; Shyamal H Mehta; Fenwick T Nichols; John C Morgan
Journal:  BMC Neurol       Date:  2015-12-18       Impact factor: 2.474

Review 7.  Glyceraldehyde-3-phosphate Dehydrogenase is a Multifaceted Therapeutic Target.

Authors:  Vladimir F Lazarev; Irina V Guzhova; Boris A Margulis
Journal:  Pharmaceutics       Date:  2020-05-02       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.